Categories: BrainNewsSeniors

REMORY: A Sea Squirt-Derived Plasmalogen Supplement Expands in the U.S. Market

REMORY: Elevate Cognitive Health with Unique Sea Squirt-Derived Plasmalogens. Now in the U.S., this Japanese-Innovated Supplement Combines EPA, DHA, and Omega-3s for Enhanced Memory and Brain Function in Aging Adults. Recognized by Japan as a ‘Food with Functional Claims,’ REMORY is FDA-Notified, Setting a New Standard in Natural Cognitive Support.

LOS ANGELES, CA / ACCESSWIRE / November 7, 2024 / With the global aging population, dementia has emerged as a critical issue worldwide. Japan, as a super-aged society, has implemented various strategies to address this challenge ahead of many other countries. In Japan, it’s anticipated that by 2025, one in five elderly individuals will be diagnosed with dementia. The World Health Organization (WHO) reports that nearly 10 million new cases of dementia arise each year globally, equating to one new case every three seconds.

REMORY: Elevate Cognitive Health with Unique Sea Squirt-Derived Plasmalogens
REMORY: Elevate Cognitive Health with Unique Sea Squirt-Derived Plasmalogens

REMORY® is a dementia support supplement derived from sea squirt plasmalogens, recognized for its benefits in Japan. Already well-received in the U.S. market, REMORY® continues to gain traction. Ongoing clinical studies further validate the efficacy of sea squirt-derived plasmalogens, with new research published in October highlighting additional promising findings.

Since its launch, Hokkori USA, the exclusive distributor known for its commitment to quality and customer satisfaction, has received enthusiastic feedback from middle-aged and older adults experiencing the product’s benefits. Interest from numerous retailers is increasing, with a media advertising campaign planned this month to broaden awareness further.

REMORY® contains plasmalogens essential for maintaining cognitive function in the human brain, making it especially suited for middle-aged and older individuals concerned about memory retention. Unlike other plasmalogen supplements, REMORY® leverages sea squirt-derived plasmalogens, also rich in EPA, DHA, and omega-3 fatty acids. Sourced exclusively from high-quality sea squirts from Hokkaido, Japan, REMORY® has earned recognition as a functional food in Japan, supporting memory retention and cognitive function in older adults and setting a new standard in natural cognitive support.

Furthermore, REMORY® is the only sea squirt-derived plasmalogen supplement in the U.S. market with functional food status approved by the Japanese government.

In Japan, where the demand for memory-support products is high, many seniors already benefit from the effects of plasmalogens.

Contact Information

Takahito Tsuchiya
Director
info@hokkori-usa.com
310-347-8750

SOURCE: REMORY®

View the original press release on newswire.com.

Staff

Recent Posts

Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Clinical trial infrastructure fully operational in the U.S. with more than 15 leading cardiovascular centers…

23 minutes ago

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

11 hours ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

14 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

14 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

14 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

14 hours ago